Lantern Pharma Inc. Common Stock (LTRN)
Lantern Pharma Inc. Common Stock (LTRN) has reported earnings 21 times since Jul 29, 2021. The stock moves an average of ±7.23% the day after reporting, closing higher 47.6% of the time. Its largest post-earnings gain was +29.21% (Nov 08, 2023) and its largest decline was -23.8% (Mar 18, 2024). The next earnings report is predicted for 2026-11-10 (estimated).
Earnings reactions
How LTRN moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±7.23%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 14, 2026 | ☀ PRE | +1.52% | open_in_new |
| May 15, 2026 | ☽ POST | -4.46% | open_in_new |
| Mar 30, 2026 | ☽ POST | +9.72% | open_in_new |
| Nov 13, 2025 | ☀ PRE | +0% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±7.23%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260814 | open_in_new SEC.gov |
| 8-K | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260804 | open_in_new SEC.gov |
| 8-K | 20260803 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260723 | open_in_new SEC.gov |
| EFFECT | 20260618 | open_in_new SEC.gov |
| S-1 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| D | 20260521 | open_in_new SEC.gov |
| 10-Q | 20260515 | open_in_new SEC.gov |
Frequently asked about LTRN earnings
When does Lantern Pharma Inc. Common Stock report earnings next? expand_more
Lantern Pharma Inc. Common Stock (LTRN)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LTRN stock move after earnings? expand_more
Over 21 reports, LTRN has moved an average of ±7.23% the session after earnings, closing higher 47.6% of the time.
What was LTRN's biggest post-earnings move? expand_more
LTRN's largest post-earnings gain on record was +29.21% on Nov 08, 2023, and its largest decline was -23.8% on Mar 18, 2024.
Where can I find Lantern Pharma Inc. Common Stock's SEC filings? expand_more
All of Lantern Pharma Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right